Cytokine Signalling Forum

Latest Podcasts

Author Interview: Professor Roy Fleischmann

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.

18th November 2021

Discussing Rheumatology: Herpes Zoster and HBV

Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in patients with RA taking tofacitinib.

31st October 2021

Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness

Paul Bird, Conjoint Professor at the University of South Wales joins Professor Peter Nash, where he discusses real-world data of tofacitinib therapy in RA

15th October 2021

Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy

Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination therapy from the Australian OPAL study.

23rd September 2021

Rheumatology Author Professor Kurt de Vlam: Pain Improvements

Kurt de Vlam, Professor of Rheumatology at UZ Leuven, Belgium.

10th September 2021

Rheumatology Author Professor Vibeke Strand: Upadacitinib and PROs

Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology/Rheumatology, Biopharmaceutical Consultant at Stanford University School of Medicine.

09th September 2021

All podcasts